The Södertörn Link Approved – A Significant Announcement for Huddinge’s Future

The government has now given its approval for the construction of the Södertörn Link, marking a significant milestone for Huddinge and the entire southern county.

On Friday, January 26, 2024, Huddinge municipality announced in a press release that the government has given the green light for the Södertörn Link, and as a result, the road plan for route 259 has gained legal force. This means that the plan can no longer be appealed.

Connecting Regional City Centers
Together with the E4 Stockholm Bypass, the Södertörn Link will connect the southern and northern parts of the county, creating new opportunities for residents, commuters, and businesses. The link will also connect several of the Stockholm region’s regional city centers, namely Kungens Kurva-Skärholmen, Flemingsberg, and Haninge Centrum.

“The approval of the link is an important announcement for the development of Huddinge and the entire southern county. Improved cross-regional communications in Södertörn give us good conditions to plan for new homes and workplaces in Huddinge and throughout Södertörn,” says Camilla Broo, Municipal Director in Huddinge.

From Kungens Kurva to Jordbro in Haninge
Now, a number of permits and decisions are awaited for the construction to commence, including the construction commencement notice from the government. Then, Trafikverket can begin constructing the two-mile-long divided motorway with a separate pedestrian and bicycle path, stretching from Kungens Kurva through Huddinge to Jordbro in Haninge.

The Södertörn Link is a national road financed by the state. Huddinge municipality has announced that they will contribute to financing the fact that the road will partly pass through a tunnel in Glömstadalen, enabling them to exploit the land and create travel demand for the South Tramway.

Published On: 28 January 2024

  • Martin Jönsson: “The time is ripe for a breakthrough in dementia treatment”

    Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.

  • AlzeCure Pharma

    The stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation

  • Bactigard

    When we needed more space to establish an integrated facility for all our activities, including production, Flemingsberg was the natural choice

  • Biomedrex Genetics

    Thanks to great contacts, including Flemingsberg Science, we quickly got a place at Ana Futura in Flemingsberg.

  • Cellaviva: improving lives through stem cell technology

    Flemingsberg is a cluster for cell therapies that gives us proximity to partners, the clinical research and the trial clinic at Karolinska Hospital where many of the patients have received their treatment.